ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 265875 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 265875; 2) Community: the network communities that were significantly associated with the response to NSC 265875; 3) Molecule: the relationships between components within communities and NSC 265875; 4) MDR: the compounds that were significantly associated with the NSC 265875.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.00617256681787881 -0.24646841
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00617256681787881 0.37086268
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.00617256681787881 -0.054003722
NSC 725098 Null 0.00617256681787881 0.21423521
NSC 726217 Combretastatin A4-analogue 0.00617256681787881 0.28448849
NSC 749169 8H-thieno[2'3':4,5]pyrimido[2,1-a]phthalazin-8-one,5-[[3-(dimethylamino)propyl]amino]-9,10-dimethyl 0.00617256681787881 -0.049218047
NSC 756401 GW832467X 0.00617256681787881 -0.0015898583
NSC 762346 Null 0.00617256681787881 0.29748455
NSC 137765 Ethanesulfonic acid, compd. with 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-N-phenylbenzeneacetamide (1:1) 0.00705866970012644 0.30142712
NSC 212446 Null 0.00705866970012644 0.36450691
Total:86  Current:15    [First] [Prev] [Next] [Last]